Robert Pierce
2022 - Sensei Biotherapeutics
In 2022, Robert Pierce earned a total compensation of $1.2M as Former Chief R&D Officer at Sensei Biotherapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Option Awards | $298,251 |
|---|---|
| Salary | $421,154 |
| Stock Awards | $90,300 |
| Other | $377,572 |
| Total | $1,187,277 |
Pierce received $421.2K in salary, accounting for 35% of the total pay in 2022.
Pierce also received $298.3K in option awards, $90.3K in stock awards and $377.6K in other compensation.
Rankings
In 2022, Robert Pierce's compensation ranked 2,697th out of 5,676 executives tracked by ExecPay. In other words, Pierce earned more than 52.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,697 out of 5,676 | 53rd |
Division Manufacturing | 1,494 out of 3,084 | 52nd |
Major group Chemicals And Allied Products | 688 out of 1,399 | 51st |
Industry group Drugs | 641 out of 1,300 | 51st |
Industry Pharmaceutical Preparations | 460 out of 942 | 51st |
Source: SEC filing on June 15, 2023.
Pierce's colleagues
We found three more compensation records of executives who worked with Robert Pierce at Sensei Biotherapeutics in 2022.